Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

Percentile
P100
Near historical high
vs 2Y Ago
7.5x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$5.00M-
2024$0.00-100.0%
2023$668000.00-
2022$0.00-
2021$0.00-
2020$0.00-